Alzheimer's Research Requires Ongoing Funding

With ongoing funding increases, scientists will be able to work at a more rapid pace to advance basic disease knowledge, explore ways to reduce risk, uncover new biomarkers for early diagnosis and drug targeting, and make discoveries that can lead to a treatment or a cure.

We are asking Congress to please include a $289 million increase in Fiscal Year 2022 for Alzheimer's research activities at the National Institutes of Health (NIH) and $20 million to implement the BOLD Infrastructure for Alzheimer’s Act at the Centers for Disease Control and Prevention (CDC) .

Without ongoing research funding to develop medical breakthroughs needed to prevent, slow or cure the disease, the number of people aged 65 and older with Alzheimer’s or other dementias could grow from 5.8 million to 13.8 million by 2050, according to the Alzheimer's Association. In 2020, Medicare and Medicaid spent an estimated $206 billion caring for those with Alzheimer’s and other dementias — 67% of total
costs. Every 65 seconds someone develops Alzheimer’s disease – which is why Congress must remain committed to action on this devastating disease.

Join me in asking Representative Marjorie Taylor Greene to support this funding increase at the NIH and CDC in the FY2022 budget.

Jim Williams
Alzheimer's Association of Georgia
Volunteer Legislative Ambassador
2020 Advocate of the Year
Ringgold, Georgia